Additional file 1: of A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Autor: Reisner, Colin, Fabbri, Leonardo, Kerwin, Edward, Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus, Ferguson, Gary, Martinez, Fernando, Donohue, James, Darken, Patrick, Rose, Earl St., Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Sarvajna Dwivedi
Rok vydání: 2017
DOI: 10.6084/m9.figshare.c.3660392_d1
Popis: Study design; Additional Fig. 1. Study design schematic; Additional Fig. 2. Mean change from baseline in PEFR over time by treatment on Day 7 (mITT population); Additional Fig. 3. Mean change from baseline FVC over time by treatment on Day 7 (mITT population); Additional Table 1. Secondary efficacy endpoints: Days 1 and 7 – FF 9.6 μg and FF 7.2 μg comparisons (mITT population). (DOCX 466 kb)
Databáze: OpenAIRE